It has been demonstrated that the inhibition of GRK2 by GRKInh, a peptide inhibitor of the kinase (62), could counteract the dysfunctional metabolism of HF in a transgenic model of myocardium-specific expression of fatty acid synthase (FASN) (63). This evidence concerns the gene GRK2 and hydrops fetalis.